Ocular toxocariasis can cause distinctive cataracts

Article

Ocular toxocariasis can cause cataract with opacity similar to granuloma, claim recent findings published in the Journal of Cataract and Refractive Surgery.

Ocular toxocariasis can cause cataract with opacity similar to granuloma, claim recent findings published in the Journal of Cataract and Refractive Surgery.

Dr Seong Joon Ahn et al, Department of Ophthalmology, Seoul National Univeristy College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea, conducted a retrospective, observational case series on 83 patients presenting with ocular toxocariasis.

Ocular toxocariasis was clinically diagnosed based on retinal granuloma with or without ocular inflammation and positive results in serum antibody enzyme-linked immunosorbent assay. The team collected demographic and ocular examination data for all patients showing atypical cataract features. Each cataract was documented with anterior segment photography.

A total of 8.4% of the patients had an atypical cataract in the eye with ocular toxocariasis only. All patients presented with small, round, white lens opacities resembling retinal granulomas.

The granulomas were mainly located in the lens midperiphery and in the subcapsular level. The lens opacity could migrate, but only did so in one patient.

For the abstract please click here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.